Miyamoto Masaaki

ミヤモトマサアキ | Miyamoto Masaaki

Affiliation and department：

Research field (4)： Cardiology , Gastroenterology , Biomaterials , Biomedical engineering

Research keywords (10)：創傷ケア , DDS , 細胞移植 , 血管再生治療 , 再生医療 , Wound healing , Drug delivery system , Cell transplantation , therapeutic angio-glnesis , Regenerative medicine

Research theme for competitive and other funds (10)：

2005 - 医療用ウジを用いた難治性潰瘍・壊疽治療
2005 - -
2001 - 難治性心血管疾患に対する血管再生療法
2001 - -
医療用無菌ウジによる難治性潰瘍・壊疽治療

Show all

Papers (8)：

Sonoko Kirinoki-Ichikawa, Gen Takagi, Yoshimitsu Fukushima, Shuhei Tara, Masaaki Miyamoto, Shinichiro Kumita. Clinical utility of 67 Gallium-SPECT/CT for determining osteotomy indication in patients with lower-limb osteomyelitis. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2023
Yu Hoshika, Yoshiaki Kubota, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, et al. Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial. Journal of cardiac failure. 2022. 28. 1. 56-64
Kosuke Mozawa, Yoshiaki Kubota, Yu Hoshika, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, et al. Empagliflozin confers reno-protection in acute myocardial infarction and type 2 diabetes mellitus. ESC heart failure. 2021. 8. 5. 4161-4173
Yu Hoshika, Yoshiaki Kubota, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, et al. Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2021. 12. 8. 2241-2248
Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, et al. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovascular diabetology. 2020. 19. 1. 148-148

ｍore...

MISC (6)：

Reversal of Diabetes in mice by xenotasplantn of a bioartificial panceas in a preuasculariz* subcytanlous site. Trasplantation. 2002. 73, 122-129
Development of a cryopratectant pracedue lmplcying a freeze* bag for panccceatic islets using a neuly develpoed cyaprctectat. Cell Transplant. 2001. 10, 363-371
Current progress and perspectuies in cell therapy for diabetes mellitus. Human Cell. 2001. 14, 293-300
Reversal of Diabetes in mice by xenotasplantn of a bioartificial panceas in a preuasculariz* subcytanlous site. Trasplantation. 2001. 73, 122-129
Development of a cryapresercatn pracedue lmplcying a freeze* bag for panccceatic islets using a neuly develpoed cyaprctectat. Cell Transplant. 2001. 10, 363-371

ｍore...

Patents (1)：

生物由来材料の消化・細胞回収方法およびその装置

Works (6)：

医療用無菌ウジによる難治性潰瘍・壊疽治療
2004 -
Maggots debridement therapy for refractory ulcer and gangreonosa
2004 -
新しいNK細胞培養法による癌免疫療法
2003 -
Cancer immunotherapy by amplified NK cells
2003 -
バイオ人工膵の開発
2002 -

ｍore...

Professional career (1)：

Work history (5)：

Nippon Medical School
Nippon Medical School Faculty of Medicine, Department of Medicine, First Dept of Medicine Associate Professor
Kyoto University Institute for Frontier Medical Sciences
Kyoto University
Associate Professor, Institute for Frontier Medicine,

Committee career (3)：

2002 - 日本組織移植学会評議員
2001 - 日本再生医療学会評議員
1999 - American college of surgeons Fellow

Awards (4)：

2003 - 第2回日本再生医療学会優秀演題賞
2003 - 東京都医師会グループ研究賞
1995 - 日本膵臓学会学会賞
1995 - Japan pancreas society

Association Membership(s) (3)：

日本組織移植学会 , 日本再生医療学会 , American college of surgeons

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page